A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to Cytarabine
Related studies linked through entity extraction aliases.
Etoposide+Cytarabine+PEG-rhG-CSF for Hematopoietic Stem Cell Mobilization in Patients With Hematological Malignancies
- Status
- UNKNOWN
- Phase
- NA
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
ChiCGB vs BEAM in High-risk or R/R Lymphomas
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Combination of Sorafenib With Standard Therapy in Newly Diagnosed Adult CBF AML
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase II Study of Cladribine and Low Dose Cytarabine in Combination With Venetoclax, Alternating With Azacitidine and Venetoclax, in Patients With Higher-risk Myeloproliferative Chronic Myelomonocytic Leukemia or Higher-risk Myelodysplastic Syndromes With Excess Blasts
- Status
- RECRUITING
- Phase
- PHASE2
Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS
- Status
- RECRUITING
- Phase
- PHASE1
GM-CLAG in Relapsed/Refractory FLT3-mutated AML
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to Treat
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Study of Liposomal Annamycin in Combination With Cytarabine for the Treatment of Subjects With Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Venetoclax to Augment Epigenetic Modification and Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE1
Treateament of Newly Diagnosed Acute Monocytic Leukemia in Children
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Venetoclax Basket Trial for High Risk Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Loncastuximab Tesirine in Combination With Chemotherapy Prior to Stem Cell Transplant for the Treatment of Recurrent or Refractory Diffuse Large B-Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
- Status
- RECRUITING
- Phase
- PHASE3
Venetoclax + Decitabine vs. "7+3" Induction Chemotherapy in Young AML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE1